Bioinformatics analysis of TCGA and CGGA datasets results showed that CDC20 was overexpressed in glioma, especially in GBM, and the increasing of CDC20 in glioma patients correlated with poorer prognosis (Fig. S3A-D). This evidence concerns the gene CDC20 and glioblastoma.